End-of-day quote
Shanghai S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
12.2
CNY
|
+10.01%
|
|
+19.61%
|
-4.84%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,134
|
2,253
|
2,142
|
5,448
|
4,519
|
4,373
|
Enterprise Value (EV)
1 |
1,960
|
2,098
|
1,983
|
5,135
|
4,314
|
3,562
|
P/E ratio
|
18
x
|
29.1
x
|
38.2
x
|
20.6
x
|
20.8
x
|
142
x
|
Yield
|
0.56%
|
0.34%
|
0.28%
|
0.54%
|
0.52%
|
-
|
Capitalization / Revenue
|
1.34
x
|
1.48
x
|
1.55
x
|
2.48
x
|
1.58
x
|
1.99
x
|
EV / Revenue
|
1.23
x
|
1.38
x
|
1.44
x
|
2.34
x
|
1.51
x
|
1.62
x
|
EV / EBITDA
|
7.58
x
|
9.36
x
|
20
x
|
10.6
x
|
10.2
x
|
15.7
x
|
EV / FCF
|
26.1
x
|
9.97
x
|
-569
x
|
38.6
x
|
18.3
x
|
25.5
x
|
FCF Yield
|
3.83%
|
10%
|
-0.18%
|
2.59%
|
5.47%
|
3.93%
|
Price to Book
|
1.67
x
|
1.68
x
|
1.55
x
|
3.32
x
|
2.6
x
|
1.38
x
|
Nbr of stocks (in thousands)
|
298,045
|
298,045
|
295,478
|
293,237
|
293,237
|
341,131
|
Reference price
2 |
7.160
|
7.560
|
7.250
|
18.58
|
15.41
|
12.82
|
Announcement Date
|
3/7/19
|
4/28/20
|
4/8/21
|
4/21/22
|
4/20/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,593
|
1,523
|
1,378
|
2,195
|
2,853
|
2,197
|
EBITDA
1 |
258.6
|
224
|
99.25
|
486.6
|
422.7
|
226.5
|
EBIT
1 |
164.3
|
119.9
|
-5.841
|
363
|
262.4
|
69.17
|
Operating Margin
|
10.32%
|
7.87%
|
-0.42%
|
16.54%
|
9.2%
|
3.15%
|
Earnings before Tax (EBT)
1 |
151.4
|
99.56
|
64.95
|
362.9
|
275.5
|
72.82
|
Net income
1 |
115.9
|
74.78
|
55.1
|
263.1
|
214.9
|
26.45
|
Net margin
|
7.28%
|
4.91%
|
4%
|
11.98%
|
7.53%
|
1.2%
|
EPS
2 |
0.3972
|
0.2600
|
0.1900
|
0.9000
|
0.7400
|
0.0900
|
Free Cash Flow
1 |
75.06
|
210.4
|
-3.485
|
133.1
|
236.1
|
139.9
|
FCF margin
|
4.71%
|
13.81%
|
-0.25%
|
6.06%
|
8.27%
|
6.37%
|
FCF Conversion (EBITDA)
|
29.03%
|
93.91%
|
-
|
27.36%
|
55.85%
|
61.78%
|
FCF Conversion (Net income)
|
64.74%
|
281.34%
|
-
|
50.61%
|
109.88%
|
528.93%
|
Dividend per Share
2 |
0.0400
|
0.0260
|
0.0200
|
0.1000
|
0.0800
|
-
|
Announcement Date
|
3/7/19
|
4/28/20
|
4/8/21
|
4/21/22
|
4/20/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
174
|
156
|
159
|
313
|
204
|
812
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
75.1
|
210
|
-3.49
|
133
|
236
|
140
|
ROE (net income / shareholders' equity)
|
9.94%
|
6.04%
|
3.6%
|
19.5%
|
11.8%
|
1.96%
|
ROA (Net income/ Total Assets)
|
5.64%
|
3.79%
|
-0.18%
|
10.4%
|
5.71%
|
1.44%
|
Assets
1 |
2,056
|
1,972
|
-30,819
|
2,534
|
3,760
|
1,843
|
Book Value Per Share
2 |
4.280
|
4.500
|
4.670
|
5.600
|
5.920
|
9.310
|
Cash Flow per Share
2 |
1.090
|
1.140
|
1.010
|
1.460
|
1.580
|
3.790
|
Capex
1 |
72.6
|
51.8
|
61.8
|
62.8
|
124
|
82.2
|
Capex / Sales
|
4.55%
|
3.4%
|
4.49%
|
2.86%
|
4.35%
|
3.74%
|
Announcement Date
|
3/7/19
|
4/28/20
|
4/8/21
|
4/21/22
|
4/20/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -4.84% | 522M | | +4.70% | 103B | | +2.40% | 65.6B | | +42.86% | 39.06B | | +16.96% | 37.58B | | +6.96% | 33.26B | | +7.89% | 19.22B | | +12.12% | 16.83B | | +12.08% | 15.03B | | +17.69% | 14.96B |
Other Commodity Chemicals
|